272 related articles for article (PubMed ID: 16848646)
1. Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.
Brawman-Mintzer O; Knapp RG; Rynn M; Carter RE; Rickels K
J Clin Psychiatry; 2006 Jun; 67(6):874-81. PubMed ID: 16848646
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
Allgulander C; Dahl AA; Austin C; Morris PL; Sogaard JA; Fayyad R; Kutcher SP; Clary CM
Am J Psychiatry; 2004 Sep; 161(9):1642-9. PubMed ID: 15337655
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
Montgomery SA; Tobias K; Zornberg GL; Kasper S; Pande AC
J Clin Psychiatry; 2006 May; 67(5):771-82. PubMed ID: 16841627
[TBL] [Abstract][Full Text] [Related]
4. Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors.
Dahl AA; Ravindran A; Allgulander C; Kutcher SP; Austin C; Burt T
Acta Psychiatr Scand; 2005 Jun; 111(6):429-35. PubMed ID: 15877709
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
Ball SG; Kuhn A; Wall D; Shekhar A; Goddard AW
J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder.
Steiner M; Allgulander C; Ravindran A; Kosar H; Burt T; Austin C
Hum Psychopharmacol; 2005 Jan; 20(1):3-13. PubMed ID: 15551351
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
Davidson JR; Bose A; Korotzer A; Zheng H
Depress Anxiety; 2004; 19(4):234-40. PubMed ID: 15274172
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
Silverstone PH; Salinas E
J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
[TBL] [Abstract][Full Text] [Related]
10. Sertraline treatment of major depression in patients with acute MI or unstable angina.
Glassman AH; O'Connor CM; Califf RM; Swedberg K; Schwartz P; Bigger JT; Krishnan KR; van Zyl LT; Swenson JR; Finkel MS; Landau C; Shapiro PA; Pepine CJ; Mardekian J; Harrison WM; Barton D; Mclvor M;
JAMA; 2002 Aug; 288(6):701-9. PubMed ID: 12169073
[TBL] [Abstract][Full Text] [Related]
11. Pregabalin versus sertraline in generalized anxiety disorder. An open label study.
Cvjetkovic-Bosnjak M; Soldatovic-Stajic B; Babovic SS; Boskovic K; Jovicevic M
Eur Rev Med Pharmacol Sci; 2015; 19(11):2120-4. PubMed ID: 26125277
[TBL] [Abstract][Full Text] [Related]
12. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
[TBL] [Abstract][Full Text] [Related]
13. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.
Rynn MA; Siqueland L; Rickels K
Am J Psychiatry; 2001 Dec; 158(12):2008-14. PubMed ID: 11729017
[TBL] [Abstract][Full Text] [Related]
14. Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?
Trivedi MH; Rush AJ; Carmody TJ; Donahue RM; Bolden-Watson C; Houser TL; Metz A
J Clin Psychiatry; 2001 Oct; 62(10):776-81. PubMed ID: 11816866
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Mehtonen OP; Søgaard J; Roponen P; Behnke K
J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
Mulholland C; Lynch G; King DJ; Cooper SJ
J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial.
Alaka KJ; Noble W; Montejo A; Dueñas H; Munshi A; Strawn JR; Lenox-Smith A; Ahl J; Bidzan L; Dorn B; Ball S
Int J Geriatr Psychiatry; 2014 Sep; 29(9):978-86. PubMed ID: 24644106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
